Hypoglycemia in association with various organic and amino acid disorders

Seminars in Perinatology

Volumn 24, Issue 2, 2000, Pages 172-193

  Ozand, P T ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; 3 METHYLGLUTACONIC ACID; ACYLCARNITINE; AMINO ACID; ARYLBUTYRIC ACID DERIVATIVE; BENZOIC ACID; BICARBONATE; CARNITINE; CISAPRIDE; COD LIVER OIL; CYANOCOBALAMIN; GLUCOSE; HYDROXOCOBALAMIN; LINOLEIC ACID; LINOLENIC ACID; MEDIUM CHAIN ACYL COENZYME A DEHYDROGENASE; METHYLMALONIC ACID; ONDANSETRON; PROPIONIC ACID; RIBOFLAVIN; THIAMINE;

ACID BASE BALANCE; AMINOACIDURIA; ARTICLE; DIET THERAPY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARLY DIAGNOSIS; ENZYME DEFICIENCY; FATTY ACID OXIDATION; GENE MUTATION; HUMAN; HYPOGLYCEMIA; MAPLE SYRUP URINE DISEASE; METABOLIC ACIDOSIS; NEUROLOGIC DISEASE; NEWBORN; PERITONEAL DIALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROPIONIC ACIDEMIA; SCREENING; TANDEM MASS SPECTROMETRY;

EID: 0034051655     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/sp.2000.6367     Document Type: Article

References (127)

1. (suppl) Al Aqeel A Rashed M Ozand PT 3-Methylglutaconic aciduria: Ten new cases with a possible new phenotype Brain Dev 16 1994 23 32
2. Gibson KM Nyhan WL Sweetman L 3-Methyl-glutaconic aciduria: A phenotype in which the activity of 3-methylglutaconyl-coenzyme A hydratase is normal Eur J Pediatr 148 1988 76 82
3. Gibson KM Elpeleg ON Jakobs C Multiple syndromes of 3-methylglutaconic aciduria Pediatr Neurol 9 1993 120 123
4. (suppl) Brismar J Ozand PT CT and MR of the brain in the diagnosis of organicacidemias Brain Dev 16 1994 104 124
5. Pettit FH Yeaman SJ Reed LJ Purification and characterization of branched chain α-ketoacid dehydrogenase complex of bovine kidney Proc Natl Acad Sci USA 75 1978 4881 4885
6. Munnich A Saudubray JM Taylor J Congenital lactic acidosis, α-ketoglutaric aciduria and variant form of maple syrup urine disease due to a single defect: Dihydrolipoyl deydrogenase deficiency Acta Paediatr Scand 71 1982 167 171
7. Scriver CR Mackenzie S Clow CL Thiamine-responsive maple-syrup-urine disease Lancet 1 1971 310 312
8. Hambraeus L Westphal O Hagberg B Ketotic hypoglycaemia associated with transient branched-chain aminoacidemia Acta Paediatr Scand 61 1972 81 89
9. Haymond MW Ben-Galim E Strobel KE Glucose and alanine metabolism in children with maple syrup urine disease J Clin Invest 62 1978 398 405
10. (suppl) Worthen HG Al Ashwal A Ozand PT Comparative frequency of hypoglycemia in selected organic acidemias, branched chain amino acidemia and disorders of fructose metabolism Brain Dev 16 1994 81 85
11. Riviello JJ Jr Rezvani I Digeorge AM Cerebral edema causing death in children with maple syrup urine disease J Pediatr 119 1991 42 45
12. Brismar J Aqeel A Brismar G Maple syrup urine disease: Findings on CT and MR scans of the brain in 10 infants Am J Neuroradiol 11 1990 1219 1228
13. Tharp BR Unique EEG pattern (comb-like rhythm) in neonatal maple syrup urine disease Pediatr Neurol 8 1992 65 68
14. Rashed MS Ozand PT Bucknall MP Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry Pediatr Res 38 1995 324 331
15. (letter) Kleijer WJ Horsman D Mancini GM First-trimester diagnosis of maple syrup urine disease on intact chorionic villi N Engl J Med 313 1985 1608
16. Kaplan P Mazur A Field M Intellectual outcome in children with maple syrup urine disease J Pediatr 119 1991 46 50
17. Sallan SE Cottom D Peritoneal dialysis in maple syrup urine disease Lancet 2 1969 1423 1424
18. Rutledge SL Havens PL Haymond MW Neonatal hemodialysis: Effective therapy for encephalopathy of inborn errors of metabolism J Pediatr 116 1990 125 128
19. Wendel U Langenbeck U Lombeck I Maple syrup urine disease-therapeutic use of insulin in catabolic states Eur J Pediatr 139 1982 172 175
20. Snyderman SE Treatment outcome of maple syrup urine disease Acta Paediatr Jpn 30 1988 417 424
21. Abstract P-129 Rabier D Narcy C Revillion HP Normalization of plasma branched-chain aminoacids (BCAAs) after liver transplantation in maple syrup urine disease (MSUD) 29th SSIEM Annual Symposium London September 10–13th 1991
22. Ozand PT Al Aqeel A Gascon G 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase deficiency in Saudi Arabia J Inherit Metab Dis 14 1991 174 188
23. Rashed MS Bucknall MP Little D Screening blood spots for inborn errors of metabolism by electrospray tandem mass spectrometry with a microplate batch process and a computer algorithm for automated flagging of abnormal profiles Clin Chem 43 1997 1129 1141
24. (suppl) Ozand PT Rashed M Gascon GG Unusual presentations of propionic acidemia Brain Dev 16 1994 46 57
25. (suppl) Lehnert W Sperl W Suormola T Propionic acidaemia: Clinical, biochemical and therapeutic aspects Eur J Pediatr 153 1994 S68 S80
26. Thompson GN Chalmers RA Walter JH The use of metronidazole in management of methylmalonic and propionic acidemia Eur J Pediatr 149 1990 792 796
27. Heidenreich R Natowicz M Hainline BE Acute extrapyramidal syndrome In methylmalonic acidemia: “Metabolic stroke” involving the globus pallidus J Pediatr 113 1988 1022 1027
28. Rutledge SL Geraghty M Mroczek E Tubulointerstitial nephritis in methylmalonic acidemia Pediatr Nephrol 7 1993 81 82
29. Ringe B Rodeck B Fangmann J Cure of hepatic-based inborn errors of metabolism by liver transplantation Transplant Proc 24 1992 2684 2686
30. Matsui SM Mahoney MJ Rosenberg LE The natural history of the inherited methylmalonic acidemias N Engl J Med 308 1983 857 861
31. Van der Meer Sb Poggi F Spada M Clinical outcome and long-term management of 17 patients with propionic acidemia Eur J Pediatr 155 1996 205 210
32. Vianey-Liaud C Divry P Gregersen N The inborn errors of mitochondrial fatty acid oxidation J Inherit Metab Dis 10 suppl 1 1987 159 200
33. Duran M Wanders RJ de Jager JP 3-hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacylcoenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment Eur J Pediatr 150 1991 190 195
34. Kolvraa S Gregersen N Christensen E In vitro fibroblast studies in a patient with C6–C10 dicarboxylic aciduria: Evidence for a defect in general acyl-CoA dehydrogenase Clin Chim Acta 126 1982 53 67
35. Gregersen N Lauritzen R Rasmussen K Suberylglycine excretion in urine from a patient with dicarboxylic aciduria Clin Chim Acta 70 1976 417 425
36. Saijo T Tanaka K Isoalloxazine ring of FAD is required for the formation of the core in the Hsp60-assisted folding of medium chain acyl-CoA dehydrogenase subunit into the assembly competent conformation in mitochondria J Biol Chem 270 1995 1899 1907
37. Bross P Andresen BS Gregersen N Impaired folding and subunit assembly as disease mechanism: the example of medium-chain acyl-CoA dehydrogenase deficiency Progr Nuc Ac Res Mol Biol 58 1998 301 337
38. Kieweg V Krautle FG Nandy A Biochemical characterization of purified human recombinant Lys304-Glu medium-chain acyl-CoA dehydrogenase containing the common disease-causing mutation and comparison with the normal enzyme Eur J Biochem 246 1997 548 556
39. (suppl) Andresen BS Bross P Jensen TG Molecular diagnosis and characterization of medium-chain acyl-CoA dehydrogenase deficiency Scan J Clin Lab Invest 220 1995 9 25
40. Matsubara U Narisawa K Tada K Medium-chain acyl-CoA dehydrogenase deficiency: Molecular aspects (review) Eur J Pediatr 151 1992 154 159
41. Ziadeh R Hoffman EP Finegold DN Medium chain acyl-CoA dehydrogenase deficiency in Pennsylvania: Neonatal screening shows high incidence and unexpected mutation frequencies Pediatr Res 37 1995 675 678
42. Zhang Z Kolvraa S Zhou Y Three RFLPs defining a haplotype associated with the common mutation in human medium-chain acyl-CoA dehydrogenase (MCAD) occur in Alu repeats Am J Hum Gen 52 1993 1111 1121
43. Yokota I Coates PM Hale DE Molecular survey of a prevalent mutation, (985) A-to-G transition, and identification of five infrequent mutations in the medium-chain acyl-CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency Am J Hum Gen 49 1991 1280 1291
44. Divry P David M Gregersen N Dicarboxylic Acta Paediatr Scand 72 1983 943 949
45. Stanley CA Hale DE Coates PM Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels Pediatr Res 17 1983 877 884
46. Allison F Bennett MJ Vriend S Acyl-coenzyme A dehydrogenase deficiency in heart tissue from infants who died unexpectedly with fatty change in liver Br Med J Clin Res Ed 296 1988 11 12
47. Roe CR Millington DS Maltby DA Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes J Pediatr 108 1986 13 18
48. Duran M Hofkamp M Rhead WJ Sudden child death and ‘healthy’ affected embers with medium-chain acyl-coenzyme A dehydrogenase deficiency Pediatrics 78 1986 1052 1057
49. Olson JE Holtzman D Sankar R Octanoic acid inhibits astrocyte volume control: Implications for cerebral edema in Reye's syndrome J Neurochem 52 1989 1197 1202
50. Njolstad PR Skjeldal OH Agsteribbe E Medium chain acyl-CoA dehydrogenase deficiency and fatal valproate toxicity Pediatr Neurol 16 1997 160 162
51. Iafolla AK Thompson RJ Rope CR Medium-chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children J Pediatr 124 1994 409 415
52. Lecoq I Mallet E Bonte JB The A985 to G mutation of the medium-chain acyl-CoA dehydrogenase gene and sudden infant death syndrome in Normandy Acta Paediatr 85 1996 145 147
53. Pollitt RJ Leonard JV Prospective surveillance study of medium chain acyl-CoA deficiency in UK Arch Dis Child 79 1998 116 119
54. Miller ME Brooks JG Forbes N Frequency of medium-chain acyl-CoA dehydrogenase deficiency C-985 mutation in sudden infant death syndrome Pediatr Res 31 1992 305 307
55. Clayton PT Doig M Chafari S Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry Arch Dis Child 79 1998 109 115
56. Matsubara Y Narisawa K Tada K Prevalence of K329E mutation in the medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards Prog Clin Biol Res 375 1992 453 462
57. Seddon HR Gray G Pollitt RJ Population screening for the common G985 mutation causing medium-chain acyl-CoA dehydrogenase deficiency with Eu-labeled oligonucleotides and the DELFIA system Clin Chem 43 1997 436 442
58. Catzeflis C Bachmann C Hale DE Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: report of two siblings Eur J Pediatr 149 1990 577 581
59. Treem WR Stanley CA Goodman SI Medium-chain acyl-CoA dehydrogenase deficiency: Metabolic effects and therapeutic efficacy of long-term-L-carnitine supplementation J Inherit Metab Dis 12 1989 112 119
60. Hale DE Batshaw ML Coates PM Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia Pediatr Res 19 1985 666 671
61. Glasgow AM Engel AG Bier DM Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium diet Pediatr Res 17 1983 319 326
62. Vianey-Saban C Divry P Brivet M Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: Clinical characteristics and diagnostic considerations in 30 patients Clin Chim Acta 269 1998 43 62
63. Treem WR Stanley CA Hale DE Hypoglycemia, hypotonia, and cardiomyopathy: The evolving clinical picture of long-chain acyl-CoA dehydrogenase deficiency Pediatrics 87 1991 328 333
64. Aoyama T Souri M Ushikubo S Purification of human very-long-chain acyl-coenzyme, A dehydrogenase and characterization of its deficiency in seven patients J Clin Invest 95 1995 2465 2473
65. Merinero B Perez-Cerda C Garcia MJ Mitochondrial very long-chain acyl-CoA dehydrogenase deficiency with a mild clinical course J Inherit Metab Dis 19 1996 173 176
66. Costa CG Dorland L de Almeida IT The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very-long-chain acyl-CoA dehydrogenase deficiency J Inherit Metab Dis 21 1998 391 399
67. Kurtz DM Rinaldo P Rhead WJ Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation Proc Natl Acad Sci USA 95 1998 15592 15597
68. Yamaguchi S Indo Y Coates PM Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency Pediatr Res 34 1993 111 113
69. Litwin SE Raya TE Anderson PG Induction of myocardial hypertrophy after coronary ligation in rats decreases ventricular dilatation and improves systolic function Circulation 84 1991 1819 1827
70. Corr PB Creer MH Yamada KA Prophylaxis of carly ventricular fibrillation by inhibition of acylcarni-tine accumulation J Clin Invest 83 1989 927 936
71. Andresen BS Olpin S Poorthuis BJ Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency Am J Hum Gen 64 1999 479 494
72. Straussberg R Harel L Varsano I Recurrent myoglobinuria as a presenting manifestation of very long chain acyl coenzyme A dehydrogenase deficiency Pediatrics 99 1997 894 896
73. Brown-Harrison MC Nada MA Sprecher H Very long chain acyl-CoA dehydrogenase deficiency: Successful treatment of acute cardiomyopathy Biochem Mol Med 58 1996 59 65
74. Cox GF Souri M Aoyama T Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme A dehydrogenase deficiency J Pediatr 133 1998 247 253
75. Ijlst L Uskikubo S Kamijo T Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: high frequency of the G1528C mutation with no apparent correlation with the clinical phenotype J Inherit Metab Dis 18 1995 241 244
76. Hagenfeldt L Venizelos N Von Dobeln U Clinical and biochemical presentation of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency J Inherit Metab Dis 18 1995 245 248
77. Tyni T Palotie A Viinikka L Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency with the G1528C mutation: clinical presentation of thirteen patients J Pediatr 130 1997 67 76
78. Wanders RJ Ijlst L Duran M Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: different clinical expression in three unrelated patients J Inherit Metab Dis 14 1991 325 328
79. Rocchicioli F Wanders RJ Aubourg P Deficiency of long-chain 3-hydroxyacyl-CoA dehydrogenase: A cause of lethal myopathy and cardiomyopathy in early childhood Pediatr Res 28 1990 657 662
80. Duran N Wanders RJ de Jager JP 3-Hydroxydi-caboxylic aciduria due to long-chain 3-hydroxy-acylcoenzyme A dehydrogenase deficiency associated with sudden neonatal death: Protective effect of medium-chain triglyceride treatment Eur J Pediatr 150 1991 190 195
81. Tyni T Pihko H Kivela T Ophthalmic pathology in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation Curr Eye Res 17 1998 551 559
82. Treem WR Shoup ME Hale DE Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency Am J Gastroenterol 91 1996 2293 2300
83. Tyni T Ekholm E Pihko H Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency Am J obst Gynecol 178 1998 603 608
84. Politt RJ Clinical and biochemical presentations in 20 cases of hydroxydicarboxylic Aciduria Tanaka K Coates PM Fatty Acid Oxidation: Clinical, Biochemical and Molecular Aspects 1990 Allan R. Liss New York, NY 495 502
85. Perez-Cerda C Merinero B Jimenez A First report of prenatal diagnosis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency in a pregnancy at risk Prenat Diag 13 1993 529 533
86. Tein I Vajsar J MacMillan L Long-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency neuropathy: Response to cod liver oil Neurol 52 1999 640 643
87. Goodman SI Loehr JP Frerman FE Clinical and biochemical aspects of glutaric acidemia type II Prog Clin Biol Res 321 1990 465 476
88. Ikeda Y Keese SM Tanaka K Biosynthesis of electron transfer flavoprotein in a cell-Free system and in cultured human fibroblasts. Defect in the alpha subunit synthesis is a primary lesion in glutaric aciduria type II J Clin Invest 78 1986 997 1002
89. Beckmann JD Frerman FE Electron-transfer flavoprotein-ubiquinone oxidoreductase from pig liver: Purification and molecular, redox, and catalytic properties Biochemistry 24 1985 3913 3921
90. Goodman SI Reale M Berlow S Glutaric acidemia type II: A form with deleterious intrauterine effects J Pediatr 102 1983 411 413
91. Lehnert W Wendel U Lindenmaier S Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. I. Clinical, metabolical, and biochemical findings Eur J Pediatr 139 1982 56 59
92. Goodman SI Frerman FE Glutaric acidaemia type II (multiple acyl-CoA dehydrogenation deficiency) J Inherit Metab Dis 7 suppl 1 1984 33 37
93. Przyrembel H Wendel U Becker K Glutaric aciduria type II: Report on a previously undescribed metabolic disorder Clin Chim Acta 66 1976 227 239
94. Niederwieser A Steinmann B Exner U Multiple acyl-CoA dehydrogenation deficiency (MADD) in a boy with nonketotic hypoglycemia, hepatomegaly, muscle hypotonia and cardiomyopathy. Detection of N-isovalerylglutamic acid and its monoamide Helv Paediatr Acta 38 1983 9 26
95. Antozzi C Garavaglia B Mora M Late-onset riboflavin-responsive myopathy with combined multiple acyl coenzyme A dehydrogenase and respiratory chain deficiency Neurol 44 1994 2153 2158
96. Araki E Kobayashi T Kohtake N A riboflavin-responsive lipid storage myopathy due to multiple acyl-CoA dehydrogenase deficiency: An adult case J Neurol Sci 126 1994 202 205
97. Mongini T Doriguzzi C Palmucci I Lipid storage myopathy in multiple acyl-CoA dehydrogenase deficiency: An adult case Eur Neurol 32 1992 170 176
98. Scholte HR Ross JD Blow W Assessment of deficiencies of fatty acyl-CoA dehydrogenases in fibroblasts, muscle and liver J Inherit Metab Dis 15 1992 347 352
99. Frerman FE Goodman SI Deficiency of electron transfer flavoprotein or electron transfer flavoprotein: Ubiquinone oxidoreductase in glutaric acidemia type II fibroblasts Proc Natl Acad Sci USA 82 1985 4517 4520
100. Gregersen N Christensen MF Christensen E Riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Assessment of 3 years of riboflavin treatment Acta Paediatr Scand 75 1986 676 681
101. de Visser M Scholte HR Schutgens RB Riboflavin-responsive lipid-storage myopathy and glutaric aciduria type II of early adult onset Neurol 36 1986 367 372
102. Green A Preece MA de Sousa C Possible deleterious effect of L-carnitine supplementation in a patient with mild multiple acyl-CoA dehydrogenation deficiency (ethylmalonic-adipic aciduria) J Inherit Metab Dis 14 1991 691 697
103. Bennett MJ Weinberger MJ Kobori JA Mitochondrial short-chain 1-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: A new defect of fatty acid oxidation Pediatr Res 39 1996 185 188
104. Niezen-Koning KE van Spronsen FJ Ijlst L A patient with lethal cardiomyopathy and carnitine-acylcarnitine translocase deficiency J Inherit Metab Dis 18 1995 230 232
105. Morris AA Olpin SE Brivet M A patient with carnitine-acylcarnitine translocase deficiency with a mild phenotype J Pediatr 132 1998 514 516
106. Chalmers RA Stanley CA English N Mitochondrial carnitine-acylcarnitine translocase deficiency presenting as sudden neonatal death J Pediatr 131 1997 220 225
107. Brivet M Slama A Millington DS Retrospective diagnosis of carnitine-acylcarnitine transferase deficiency by acylcarnitine analysis in the proband Guthrie card and enzymatic studies in the parents J Inherit Metab Dis 19 1996 181 184
108. Stanley CA Hale DE Berry GT Brief report: a deficiency of carnitine-acylcarnitine translocase in the inner mitochondrial membrane N Engl J Med 327 1992 19 23
109. Dimauro S Trevisan C Carnitine plamityltransferase (CPT) deficiency: A review Schotland DL Disorders of the Motor Unit 1982 John Wiley & Sons New York, NY 657 666
110. Demaugre F Bonnefont JP Mitchell G Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: Two distinct entities Pediatr Res 24 1988 308 311
111. Kolodziej MP Crilly PJ Cortrophine CG Development and characterization of a polyclonal antibody against rat liver mitochondrial overt carnitinepalmitoyl transferase (CPT I). Distinction of CPT I from CPT II and isoforms of CPT I in different tissues Biochem J 282 1992 415 421
112. Bonnefont JP Haas R Wolff J Deficiency of carnitine palmitoyl transferase I J Child Neurol 4 1989 198 203
113. Stanley CA Sunaryo F Hale DE Elevated plasma carnitine in the hepatic form of carnitine palmitoyl transferase-1 deficiency J Inherit Metab Dis 15 1992 785 789
114. Haworth J Demaugre F Boothe FA Atypical features of the hepatic form of carnitine palmitoyl transferase deficiency in a Hutterite family J Pediatr 121 1992 553 557
115. Mitsubuchi H Matsuda I Nobukuni Y Gene analysis of Mennonite maple syrup urine disease kindred using primer-specified restriction map modification J Inherit Metab Dis 15 1992 181 187
116. Nobukuni Y Mitsubuchi H Akaboshi I Maple syrup urine disease. Complete defect of the E1 βsubunit of the branched chain α-keto acid dehydrogenase complex due to a deletion of an 11 bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease J Clin Invest 87 1991 1862 1866
117. Liu TC Kim H Arizmendi C Identification of two missense mutations in a dihydrolipoamide dehydrogenase-deficient patient Proc Natl Acad Sci USA 90 1993 5186 5190
118. Mitchell GA Ozand PT Robert MF HMG CoA lyase deficiency: Identification of five causal point mutations in codons 41 and 42, including a frequent Saudi Arabian mutation, R41Q Am J Hum Genet 62 1998 295 300
119. Ohura T Kraus JP Rosenberg LE Unequal synthesis and differential degradation of propionyl CoA carboxylase subunits in cells from normal and propionic acidemia patients Am J Hum Genet 45 1989 33 40
120. Adjalla CE Hosack AR Gilfix BM Seven novel mutations in must methylmalonic aciduria Hum Mutat 11 1998 270 274
121. Andresen BS Vianey-Saban C Bross The mutational spectrum in very long-chain acyl-CoA dehydrogenase deficiency J Inherit Metab Dis 19 1996 169 172
122. Indo Y Glassberg R Yokota I Molecular characterization of variant alpha-subunit of electron transfer flavoprotein in three patients with glutaric acidemia type II—and identification of glycine substitution for valine-157 in the sequence of the precursor, producing an unstable mature protein in a patient Am J Hum Gen 49 1991 575 580
123. Freneaux E Sheffield VC Molin L Glutaric acidemia type II. Heterogeneity in beta-oxidation flux, polypeptide synthesis, and complementary DNA mutations in the alpha subunit of electron transfer flavoprotein in eight patients J Clin Invest 90 1992 1679 1686
124. Huizing M Iacobazzi V Ijlst L Cloning of the human carnitine-acylcarnitine carrier cDNA and identification of the molecular defect in a patient Am J Hum Gen 61 1997 1239 1245
125. Ijlst L Mandel H Oostheim W Molecular basis of hepatic carnitine palmitoyltransferase I deficiency J Clin Invest 102 1998 527 531
126. Ozand PT Evaluation of a newborn with a potential metabolic defect Cowett R Principles of Perinatal-Neonatal Metabolism 1998 Springer-Verlag New York, NY 1201 1242
127. Rashed MS Rahbeeni Z Ozand PT Application of electrospray tandem mass spectrometry to neonatal screening Sem Perinatol 23 1999 183 193